Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer Chapter uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Genes, BRCA1
  • Genes, BRCA2
  • Genetic Predisposition to Disease
  • Mutation

abstract

  • © 2011 Future Medicine Ltd. All rights reserved.Single-agent PARP inhibitors have produced responses in BRCA mutation-associated breast cancer. There are limited data regarding the effects of single-agent PARP inhibitors in sporadic TNBC. Combinations of PARP inhibitors with conventional cytotoxic agents are being studied in both hereditary and sporadic breast cancer. The results of the iniparib Phase III study may not generalize to other PARP inhibitor studies, given differences in patient populations and the activities of the compounds.

publication date

  • November 2011

Research

keywords

  • Book Chapter

Identity

Digital Object Identifier (DOI)

  • 10.2217/EBO.11.100

Additional Document Info

start page

  • 61

end page

  • 69